NO975862L - P-selektinligander og relaterte molekyler og fremgangsmåter - Google Patents

P-selektinligander og relaterte molekyler og fremgangsmåter

Info

Publication number
NO975862L
NO975862L NO975862A NO975862A NO975862L NO 975862 L NO975862 L NO 975862L NO 975862 A NO975862 A NO 975862A NO 975862 A NO975862 A NO 975862A NO 975862 L NO975862 L NO 975862L
Authority
NO
Norway
Prior art keywords
methods
ligands
determinant
selectin ligands
related molecules
Prior art date
Application number
NO975862A
Other languages
English (en)
Other versions
NO975862D0 (no
Inventor
Brian Seed
Tara Pouyani
Original Assignee
Gen Hospital Corp
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Gen Hospital Corp filed Critical Gen Hospital Corp
Publication of NO975862D0 publication Critical patent/NO975862D0/no
Publication of NO975862L publication Critical patent/NO975862L/no

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/02—Peptides of undefined number of amino acids; Derivatives thereof
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/705—Receptors; Cell surface antigens; Cell surface determinants
    • C07K14/70596—Molecules with a "CD"-designation not provided for elsewhere
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P13/00—Drugs for disorders of the urinary system
    • A61P13/02—Drugs for disorders of the urinary system of urine or of the urinary tract, e.g. urine acidifiers
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00—Drugs for genital or sexual disorders; Contraceptives
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/02—Immunomodulators
    • A61P37/04—Immunostimulants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P5/00—Drugs for disorders of the endocrine system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/46—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates
    • C07K14/47—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals
    • C07K14/4701—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals not used
    • C07K14/4727—Mucins, e.g. human intestinal mucin
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/46—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates
    • C07K14/47—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals
    • C07K14/4701—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals not used
    • C07K14/473—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals not used alpha-Glycoproteins
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/705—Receptors; Cell surface antigens; Cell surface determinants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K2319/00—Fusion polypeptide

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Organic Chemistry (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Pharmacology & Pharmacy (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Immunology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Genetics & Genomics (AREA)
  • Molecular Biology (AREA)
  • Toxicology (AREA)
  • Zoology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Biophysics (AREA)
  • Biochemistry (AREA)
  • Endocrinology (AREA)
  • Cell Biology (AREA)
  • Pulmonology (AREA)
  • Oncology (AREA)
  • Epidemiology (AREA)
  • Reproductive Health (AREA)
  • Pain & Pain Management (AREA)
  • Rheumatology (AREA)
  • Communicable Diseases (AREA)
  • Urology & Nephrology (AREA)
  • Diabetes (AREA)
  • Cardiology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)

Abstract

Her er beskrevet organiske molekyler som har bundet via en kovalent binding en sialyl-Le" determinant og en sulfatert determinant, der minst en av disse determinanter er plassert på et ikke-naturlig område på molekylet. Det beskrives også spesielle P-selektinligander og P-selektinligand antistoff fusjoner. Disse molekyler, ligander og fusjonsproteiner er til bruk i fremgangsmåter for å redusere eller beskytte mot betennelse og uønskede reaksjoner avhengig av blodårelekkasje, slik som organskade og blodlevring (for eksempel assosiert med voksent respiratorisk lidelsessyndrom eller ischemisk hjerteskade).
NO975862A 1995-06-14 1997-12-12 P-selektinligander og relaterte molekyler og fremgangsmåter NO975862L (no)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US21395P 1995-06-14 1995-06-14
PCT/US1996/010043 WO1997000079A1 (en) 1995-06-14 1996-06-11 P-selectin ligands and related molecules and methods

Publications (2)

Publication Number Publication Date
NO975862D0 NO975862D0 (no) 1997-12-12
NO975862L true NO975862L (no) 1998-02-12

Family

ID=21690430

Family Applications (1)

Application Number Title Priority Date Filing Date
NO975862A NO975862L (no) 1995-06-14 1997-12-12 P-selektinligander og relaterte molekyler og fremgangsmåter

Country Status (14)

Country Link
EP (1) EP0833650A4 (no)
JP (1) JPH11508131A (no)
KR (1) KR19990022954A (no)
AR (1) AR003436A1 (no)
AU (1) AU6272996A (no)
BR (1) BR9608918A (no)
CA (1) CA2224625A1 (no)
CZ (1) CZ401497A3 (no)
HU (1) HUP9901131A2 (no)
IL (1) IL122590A0 (no)
NO (1) NO975862L (no)
TR (1) TR199701620T1 (no)
WO (1) WO1997000079A1 (no)
ZA (1) ZA965032B (no)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU2975599A (en) * 1998-02-27 1999-09-15 Genetics Institute Inc. P-selectin ligand protein including tetrameric fusion proteins
EP1406930A4 (en) * 2000-12-29 2007-01-10 Savient Pharmaceuticals Inc "ISOLATED MOLECULES WITH SULFATED GROUPING CONTAINING EPITOPES, ANTIBODIES AGAINST SUCH EPITOPES AND USES THEREOF"
JP4599027B2 (ja) * 2002-10-30 2010-12-15 東洋水産株式会社 Ｌ−セレクチン結合阻害剤

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ES2183851T3 (es) * 1990-07-17 2003-04-01 Univ Oklahoma Ligando de gmp-140.
US5318890A (en) * 1991-05-06 1994-06-07 The Regents Of The University Of California Assays for inhibitors of leukocyte adhesion
AU681369B2 (en) * 1992-11-16 1997-08-28 Board Of Regents Of The University Of Oklahoma, The Glycoprotein ligand for P-selectin and methods of use thereof
WO1995030001A2 (en) * 1994-04-28 1995-11-09 Genetics Institute, Inc. Novel p-selectin ligand protein

Also Published As

Publication number Publication date
JPH11508131A (ja) 1999-07-21
WO1997000079A1 (en) 1997-01-03
AU6272996A (en) 1997-01-15
IL122590A0 (en) 1998-06-15
BR9608918A (pt) 1999-06-15
KR19990022954A (ko) 1999-03-25
ZA965032B (en) 1997-03-14
HUP9901131A2 (hu) 1999-07-28
CA2224625A1 (en) 1997-01-03
EP0833650A4 (en) 2005-01-19
TR199701620T1 (xx) 1998-05-21
AR003436A1 (es) 1998-08-05
EP0833650A1 (en) 1998-04-08
CZ401497A3 (cs) 1998-07-15
NO975862D0 (no) 1997-12-12

Similar Documents

Publication Publication Date Title
US5811005A (en) Apparatus for intravenous administration of solutions of cell-free hemoglobin including a nitroxide bound to a matrix
Gahmberg et al. Selective radioactive labeling of cell surface sialoglycoproteins by periodate-tritiated borohydride.
Berndt et al. Purification and preliminary physicochemical characterization of human platelet membrane glycoprotein V.
Perutz Nature of haem–haem interaction
Kassis et al. Mechanism of action of cholera toxin on intact cells. Generation of A1 peptide and activation of adenylate cyclase.
NO941703L (no) Fremstiling og anvendelse av multimere hemoglobiner
DK0710228T3 (da) Hydraziner med N3S-konfiguration som radionuclidchelatorer
NO20051950L (no) Konjugater av et polypeptid og en biokompatibel polymer
CA2111092A1 (en) Specifically Beta-Beta Cross-Linked Hemoglobins and Method of Preparation
Nieuwenhuizen Fibrin‐mediated plasminogen activation
AU2387088A (en) Cationized antibodies for delivery through the blood-brain barrier
ES427365A1 (es) Un metodo de aislamiento de uno al menos de los factores decoagulacion de la sangre: fibrinogeno, factor viii antihe- mofilia y factor b.
WO1994029351A3 (en) Antibodies
AU7528894A (en) Hydrazino-type n2s2 chelators
DK644388A (da) Farmaceutiske praeparater indeholdende 3-hydroxy-smoeresyrederivater
AU1378395A (en) Metal chelators
DK0413188T3 (da) Fremgangsmåde til fremstilling af umodificerede, intravenøst administrerbare IgM- og/eller IgA-holdige immunglobulinpræparater
ATE158082T1 (de) Bestimmung von peptidmotiven auf mhc-molekülen
NO176807C (no) Sammensmeltet gen som koder for et hybridprotein, samt fremgangsmåte for fremstilling av et hybridprotein som kodes av et sammensmeltet gen; vektor og sammensmeltet gen
NO975862L (no) P-selektinligander og relaterte molekyler og fremgangsmåter
NO993151L (no) Fremgangsmåte for fremstilling av renset dimer av benavledet faktor
EP0393895A3 (en) Silicometallate molecular sieves and their use as catalysts in oxidation of alkanes
Elbaum et al. Surface activity of hemoglobin S and other human hemoglobin variants
Guillochon et al. Studies on haemoglobin immobilized by cross-linking with glutaraldehyde cross-lInked soluble polymers and artificial membranes
DK0629238T3 (da) Autotaxin:Motilitetsstimulerende protein, som er nyttigt til cancerdiagnose og terapi